231 related articles for article (PubMed ID: 33215260)
21. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
22. A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses.
Wu F; Zhang S; Zhang Y; Mo R; Yan F; Wang H; Wong G; Chi H; Wang T; Feng N; Gao Y; Xia X; Zhao Y; Yang S
Viruses; 2020 Jan; 12(1):. PubMed ID: 31947873
[TBL] [Abstract][Full Text] [Related]
23. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
[TBL] [Abstract][Full Text] [Related]
24. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
[TBL] [Abstract][Full Text] [Related]
25. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U
J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575
[TBL] [Abstract][Full Text] [Related]
26. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
[TBL] [Abstract][Full Text] [Related]
27. Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles.
Dhanasooraj D; Kumar RA; Mundayoor S
Int J Nanomedicine; 2013; 8():835-43. PubMed ID: 23486691
[TBL] [Abstract][Full Text] [Related]
28. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
29. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR
J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598
[TBL] [Abstract][Full Text] [Related]
30. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
31. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.
Chu X; Li Y; Long Q; Xia Y; Yao Y; Sun W; Huang W; Yang X; Liu C; Ma Y
Int J Nanomedicine; 2016; 11():2417-29. PubMed ID: 27313455
[TBL] [Abstract][Full Text] [Related]
32. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
33. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
[TBL] [Abstract][Full Text] [Related]
34. The position of Spy Tag/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine.
Sheng Y; Li Z; Lin X; Ma Y; Ren Y; Su Z; Ma G; Zhang S
Vaccine; 2023 Jul; 41(33):4867-4878. PubMed ID: 37391312
[TBL] [Abstract][Full Text] [Related]
35. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
[TBL] [Abstract][Full Text] [Related]
36. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R
J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531
[TBL] [Abstract][Full Text] [Related]
37. Cloning and expression of Che a 1, the major allergen of Chenopodium album in Escherichia coli.
Vahedi F; Sankian M; Moghadam M; Mohaddesfar M; Ghobadi S; Varasteh AR
Appl Biochem Biotechnol; 2011 Apr; 163(7):895-905. PubMed ID: 20872185
[TBL] [Abstract][Full Text] [Related]
38. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
[TBL] [Abstract][Full Text] [Related]
39. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen.
Hartl A; Kiesslich J; Weiss R; Bernhaupt A; Mostböck S; Scheiblhofer S; Ebner C; Ferreira F; Thalhamer J
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):107-13. PubMed ID: 9893193
[TBL] [Abstract][Full Text] [Related]
40. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
Raz E; Tighe H; Sato Y; Corr M; Dudler JA; Roman M; Swain SL; Spiegelberg HL; Carson DA
Proc Natl Acad Sci U S A; 1996 May; 93(10):5141-5. PubMed ID: 8643542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
